about
Hyporeninemic hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for managementSerious adverse events experienced by patients with chronic heart failure taking spironolactoneInappropriate secretion of antidiuretic hormone associated with lorazepamReversible impairment of renal function associated with enalapril in a diabetic patient.Hyporeninemic hypoaldosteronism complicating primary autonomic insufficiencyHyperkalemia.Diabetes and drug-associated hyperkalemia: effect of potassium monitoring.Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.Sustained-release potassium chloride overdose.Diabetes mellitus and electrolyte disorders.Hyperkalemia: a review.Advances in treatment of hyperkalemia in chronic kidney disease.Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis.Renin knockout rat: control of adrenal aldosterone and corticosterone synthesis in vitro and adrenal gene expression.Acid-base and electrolyte abnormalities observed in patients receiving cardiovascular drugs.Electrolyte and acid-base disturbances in diabetes mellitus.Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder.New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.Hyponatraemia: biochemical and clinical perspectives.Changes in urinary potassium excretion in patients with chronic kidney disease.Differential diagnosis of hyperkalemia: an update to a complex problem.Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.Pathophysiology, diagnosis, and treatment of mineralocorticoid disorders.Management of hyperkalaemia in chronic kidney disease.How Dangerous Is Hyperkalemia?Hyperkalaemia in diabetes: prevalence and associations.Unique chloride-sensing properties of WNK4 permit the distal nephron to modulate potassium homeostasis.Fludrocortisone for heparin-induced hyperkalemia.Selected developments in the understanding of diabetic ketoacidosis.Pseudohypoaldosteronism: case report and discussion of the syndrome.Potassium balances in maintenance hemodialysis.Hyponatremia in an Elderly Patient due to Isolated Hypoaldosteronism Occurring after Licorice Withdrawal.Serum potassium in dual renin-angiotensin-aldosterone system blockade.Fludrocortisone therapy for persistent hyperkalaemia.Challenges in the acute management of profound hyponatremia presenting with severe symptoms.Acute tubular dysfunction in infants with obstructive uropathy.Maternally-inherited diabetes with deafness (MIDD) and hyporeninemic hypoaldosteronism.A relationship between serum potassium concentration and insulin resistance in patients with type 2 diabetes mellitus.Increased plasma renin activity in type 1 diabetes with microvascular disease.
P2860
Q26765228-E6237191-8C5F-45CF-B274-71E903EA5E9CQ28360281-7FC4187D-ED2D-4F2D-AAC8-3C629DC9F719Q28361061-257CF3BE-BDF7-4337-8592-F883A8754297Q28369410-8BA314B4-2ED1-488F-895D-30012567CB3EQ33174222-E2663DB4-4002-47A2-91C0-A49FE8CDAE2AQ33581352-196D4DF9-D1A6-4FBB-A668-874503531C9CQ33742539-9B257A08-E66E-474C-9233-522D72297DC7Q33815762-6E88B6D9-7C39-4E98-8CA4-7A1B9B0A149AQ34106924-DF98494F-A667-493D-9840-FA6030FAFCB7Q34344884-087ACDC2-4B9B-481A-8121-72A5748C03A7Q34448823-012E98B4-9271-4899-BFDC-8F4E68440C4BQ34491934-47D2B610-CBF9-4AA3-8C27-8CAC8E491E3CQ34753785-B17FF2C0-0773-40E2-994C-B11D14F80405Q34800872-4DF846BB-CFF2-4EDB-B2F4-9F300D048EDFQ35636701-D3F7ABB3-C5EA-467E-90DF-9301238F4A16Q36004837-39C4FE89-39D4-4C8D-A505-955F4636A848Q36069231-2D2F12D6-2066-497E-9C46-126BDA9BA827Q36191021-F3C1FDAB-EAD2-403A-BADB-16C5675AD6B6Q36613331-F3D38C33-72E9-4147-81DC-817B9DAD3A43Q37034971-A670FBDA-AC2A-4433-B919-576D0CDD0611Q37082990-512E98C3-1204-4B83-B93B-22412E1C6ADBQ37925006-9CD273A0-39AB-41E3-BC47-B0E1E8053B89Q38052452-5FED869C-3FB6-4FE2-9FBB-72C88DB0A173Q38221451-5353AD08-35A7-48EC-98E8-31E6F3B9A164Q38249892-3CABF3E4-F19C-486E-A5DE-1BBB9B9F7F5EQ38639874-56CF59B6-896F-48FF-91B6-76C08BE2DD1CQ38640636-C33043CB-7396-41C5-8166-E179154F4BF9Q39698346-C9541411-DF50-4320-954B-A1BDB4D9714CQ39911405-5581277A-E5F8-4081-8254-29083F979ECAQ40206328-A2DBE926-14F5-41B0-B2D4-F0076C5B2C06Q41564697-10FD58D3-3833-4843-9767-42682E698ED9Q41907997-2E61E7BC-6A87-4113-BEBB-4AEF578BF8AEQ42318275-57315560-8607-479E-823F-83763FD3AF0BQ42624224-65CDC2E4-493E-4C77-B1DD-47605B3D3CBBQ47925566-177C7851-6B4B-4B8A-9DA9-977684019F4AQ48008518-1023CEF4-1185-4053-A853-029C20D6C4BDQ49184847-CD1FA740-FADE-494A-8401-B9D8F6E4324BQ50357795-DB205036-F2DF-44DF-A2C5-BDE6249A6EA5Q51025486-FBEAAE99-DFE7-48A7-B295-DB10E6E0D2D1Q51651044-84878A07-67C5-4190-B3F6-E85A4EF8EB57
P2860
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Hyperkalemia and hyporeninemic hypoaldosteronism
@ast
Hyperkalemia and hyporeninemic hypoaldosteronism
@en
Hyperkalemia and hyporeninemic hypoaldosteronism
@nl
type
label
Hyperkalemia and hyporeninemic hypoaldosteronism
@ast
Hyperkalemia and hyporeninemic hypoaldosteronism
@en
Hyperkalemia and hyporeninemic hypoaldosteronism
@nl
prefLabel
Hyperkalemia and hyporeninemic hypoaldosteronism
@ast
Hyperkalemia and hyporeninemic hypoaldosteronism
@en
Hyperkalemia and hyporeninemic hypoaldosteronism
@nl
P3181
P356
P1433
P1476
Hyperkalemia and hyporeninemic hypoaldosteronism
@en
P2093
R A DeFronzo
P2888
P304
P3181
P356
10.1038/KI.1980.14
P407
P577
1980-01-01T00:00:00Z
P5875
P6179
1003864297